[ Price : $8.95]
FDA says there is a potential for healthcare facility staff to misinterpret indicator colors used to signify whether a medical dev...[ Price : $8.95]
TG Therapeutics announces positive topline results from the UNITY-CLL Phase 3 trial evaluating the combination of umbralisib plus ...[ Price : $8.95]
FDA approves Grifols Procelix Panther System for use with several U.S. licensed Procelix assays.[ Price : $8.95]
FDA warns the University of Kentucky laboratory about deviations from good laboratory practices for nonclinical studies.[ Price : $8.95]
A whistleblower report by ousted Biomedical Advanced Research and Development Authority director Rick Bright details the roles of ...[ Price : $8.95]
FDA issues a guidance to aid development and clinical trial designs for drugs to treat cytomegalovirus in specified post-transplan...[ Price : $8.95]
Federal Register notice: FDA announces that it is abandoning a 9/2017-published approach that would have enabled device sponsors t...[ Price : $8.95]
FDA approves AstraZenecas Farxiga (dapagliflozin) oral tablets for adults with heart failure with reduced ejection fraction to red...